Referenties

Basu, S., Bhattacharyya, K.B., Das, K., Das, D. (2005). Comparative study of sodium valproate and lamotrigine as monotherapy in the management of typical absence seizures. Epilepsia, 46(6), 277.

Brigo, F., & Igwe, S. C. (2017). Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev, 2, Cd003032. doi: 10.1002/14651858.CD003032.pub3.

Fattore, C., Boniver, C., Capovilla, G., Cerminara, C., Citterio, A., Coppola, G., Costa, P., Darra, F., Vecchi, M., Perucca, E. (2011). A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. Epilepsia 52(4), 802-9. doi: 10.1111/j.1528-1167.2010.02976.x.

Glauser, T.A., Cnaan, A., Shinnar, S., Hirtz, D.G., Dlugos, D., Masur ,D., Clark, P.O., Capparelli, E.V., Adamson, P.C., Childhood Absence Epilepsy Study Group. (2010). Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med. 362(9),790-9. doi: 10.1056/NEJMoa0902014

Glauser T.A., Cnaan A., Shinnar S., Hirtz D.G., Dlugos D., Masur D., Clark P.O., Adamson P.C.; Childhood Absence Epilepsy Study Team. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia. 2013;54(1):141-55. 

Huang, T.‐S., Zhu, J‐L., Li ,B., Hu, Y., Chen, L., Liao, J‐X. (2009). Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children. Zhongguo Dangdai Erke Zazhi, 11(8), 653‐5.

Masur D., Shinnar S., Cnaan A., Shinnar R.C., Clark P., Wang J., Weiss E.F., Hirtz D.G., Glauser T.A. Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy. Neurology 2013;81;1572-80.

Posner EB, Mohamed KK, Marson AG. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database of Systematic Reviews 2005, Issue 4. DOI: 10.1002/ 14651858.CD003032.pub2.

Raspall-Chaure M, Neville B, Scott RC (2008). The medical management of the epilepsies in children: conceptual and practical considerations. Lancet Neurol. 7(1):57-69.

Schmitt, B., Kovacevic-Preradovic, T., Critelli, H., Molinari, L. (2007). Is ethosuximide a risk factor for generalised tonic-clonic seizures in absence epilepsy? Neuropediatrics 38 (2),83-7.

Thomas P, Valton L, Genton P (2006). Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 129:1281-92.

Trudeau, V., Myers, S., LaMoreaux, L., Anhut, H., Garofalo, E., Ebersole, J. (1996). Gabapentin in naive childhood absence epilepsy: results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol. 11(6), 470-5.

http://www.fk.cvz.nl/